Drug General Information
Drug ID
D0RL3T
Former ID
DIB008747
Drug Name
TEN-010
Indication Advanced solid tumor [ICD9: 140-199; ICD10:C00-C75, C7A, C7B] Phase 1 [525017]
Company
Tensha therapeutics
Target and Pathway
Target(s) Bromodomain-containing protein 4 Target Info Modulator
WikiPathways Chemical Compounds to monitor Proteins
References
Ref 525017ClinicalTrials.gov (NCT02308761) A Dose Escalation and Cohort Expansion Study of TEN-010 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.